MYD88 and osteomyelitis: Since activation of the osteocyte MYD88 pathway is a significant cause of inflammatory osteolysis due to bacterial infection, targeting the MYD88 signaling and downstream RANKL regulatory mechanisms in osteocytes would be a treatment strategy for bone destruction in periodontitis and osteomyelitis.